ATyr Pharma amended its $20 million credit agreement with lenders Silicon Valley Bank and Solar Capital.

According to a related 8-K filing, the amendment provides up to $5 million in the second tranche of term loans that may be drawn down at any time before the earlier of June 30 or an event of default and an additional $5 million in third tranche of term loans that may be drawn down at any time after June 30 and before December 31, 2017.

The second tranche of $5 million was funded on June 30, 2017.